GLP-1 Receptor Agonists (Injectable/Oral)

GLP-1 receptor agonists are highly effective, FDA-approved medications for type 2 diabetes and obesity management, mimicking hormones that reduce blood sugar, slow gastric emptying, and promote satiety. Common options include injectable weekly Ozempic, Mounjaro, and daily Rybelsus (oral). They are widely used to manage weight and improve heart/kidney health, though side effects often include gastrointestinal discomfort